Brief: InspireMD Announces Inclusion Of Its CGuard Carotid Stent In Crest-2 Trial
28/02/2022 12:48
Feb 28 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES THE INCLUSION OF ITS CGUARD CAROTID
STENT IN
CREST-2 TRIAL FOLLOWING FDA APPROVAL OF THE INVESTIGATIONAL
DEVICE EXEMPTION SUPPLEMENT APPLICATION
Source text for Eikon: ID:nGNXB5HKs
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))